Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.

[1]  Emma Hall,et al.  Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. , 2012, The New England journal of medicine.

[2]  A. Niemierko,et al.  Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. , 2012, European urology.

[3]  Deborah Schrag,et al.  Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment. , 2011, The oncologist.

[4]  M. Milowsky,et al.  Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy , 2011, Therapeutic advances in urology.

[5]  E. Ward,et al.  The Association of Insurance and Stage at Diagnosis Among Patients Aged 55 to 74 Years in the National Cancer Database , 2010, Cancer journal.

[6]  S. Edge,et al.  Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  E. Solsona,et al.  Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer. , 2010, The Journal of urology.

[8]  John L Adams,et al.  Use of radical cystectomy for patients with invasive bladder cancer. , 2010, Journal of the National Cancer Institute.

[9]  D. Forman,et al.  A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK. , 2010, International journal of radiation oncology, biology, physics.

[10]  David C. Smith,et al.  A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219). , 2009, The Journal of urology.

[11]  L. Koniaris,et al.  Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease. , 2008, The Journal of urology.

[12]  A. Kiltie,et al.  Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. , 2008, International journal of radiation oncology, biology, physics.

[13]  Xifeng Wu,et al.  Organ preservation for muscle-invasive bladder cancer by transurethral resection. , 2007, Urology.

[14]  P. Carroll,et al.  Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. , 2007, The Journal of urology.

[15]  John T. Wei,et al.  Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. , 2004, Urology.

[16]  Sten Nilsson,et al.  Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies. , 2004, European urology.

[17]  Nicholas J Vogelzang,et al.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.

[18]  D. Forman,et al.  A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. , 2003, European urology.

[19]  J. Dunst,et al.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  V. Shavers,et al.  Racial and ethnic disparities in the receipt of cancer treatment. , 2002, Journal of the National Cancer Institute.

[21]  T. Wilt,et al.  Surgery versus radiotherapy for muscle invasive bladder cancer? , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[22]  R. Macchia,et al.  Radical transurethral resection in the management of muscle-invasive bladder cancer. , 2001, Journal of endourology.

[23]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[24]  H. Herr,et al.  Conservative management of muscle-infiltrating bladder cancer: prospective experience. , 1987, The Journal of urology.

[25]  K. Guru,et al.  ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. , 2013, European urology.

[26]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[27]  E. Ward,et al.  Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. , 2011, The Journal of urology.

[28]  H. Grossman,et al.  Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study. , 2001, The Journal of urology.

[29]  H. Herr,et al.  Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  K Y Liang,et al.  An overview of methods for the analysis of longitudinal data. , 1992, Statistics in medicine.